[Federal Register Volume 61, Number 204 (Monday, October 21, 1996)]
[Notices]
[Page 54686]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-26888]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission will convene a meeting
of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on
November 14-15, 1996. The meeting will take place at the address
provided below. All sessions of the meeting will be open to the public,
except where specifically noted otherwise.
Topics of discussion will include: (1) Discussion of Strategic
Assessment and Direction Setting Issues Papers, (2) Status reports on
(a) the Advance Notice for Proposed Rulemaking for Part 33, ``Specific
Domestic Licensees of Broad Scope for Byproduct Material,'' (b) Modules
for Regulatory Guide 10.8, ``Guide for the Preparation of Applications
for Medical Use Programs,'' (c) Memorandum of Understanding with the
U.S. Food and Drug Administration, and (d) Continuing Implementation of
the Quality Management Rule; (3) discussion of regulatory authorization
for intravascular brachytherapy, including the petition of IsoStent
intravascular brachytherapy and the development of criteria and
training and experience requirements; (4) discussion of security and
control of byproduct materials in medical and university settings; (5)
discussion of mobile high-dose-rate afterloader applications; and (6)
discussion of inspection guidance for the final rule on patient
release. The staff will also provide an update on several rulemakings
and regulatory guides: (1) Petition by Tri-Med for carbon-14 use; (2)
Release of Patients (10 CFR 35.75); (3) ``Reporting Requirements for
Unauthorized Use of Licensed Radioactive Material;'' and (4) Regulatory
Guide for the final rule, ``Preparation, Transfer for Commercial
Distribution, and Use of Byproduct Material for Medical Use.'' In
addition, on November 14, 1996, 8:00 a.m.--9:00 a.m., there will be a
closed session of the ACMUI to discuss ethics rules and their
application. This session will be closed to prevent invasion of
personal privacy of committee members.
DATES: The meeting will begin at 9 a.m., on November 14, 1996, and 8:00
a.m. on November 15, 1996.
ADDRESSES: U.S. Nuclear Regulatory Commission, Two White Flint North,
11545 Rockville Pike, Room T2B3, Rockville, MD 20852-2738.
FOR FURTHER INFORMATION, CONTACT: Torre Taylor, U.S. Nuclear Regulatory
Commission, Office of Nuclear Material Safety and Safeguards, MS T8F5,
Washington, DC 20555, Telephone (301) 415-7900.
Conduct of the Meeting
Judith Ann Stitt, M.D., will chair the meeting. Dr. Stitt will
conduct the meeting in a manner that will facilitate the orderly
conduct of business. The following procedures apply to public
participation in the meeting:
1. Persons who wish to provide a written statement should submit a
reproducible copy to Torre Taylor (address listed previously), by
November 8, 1996. Statements must pertain to the topics on the agenda
for the meeting.
2. At the meeting, questions from members of the public will be
permitted at the discretion of the Chairman.
3. The transcript and written comments will be available for
inspection, and copying, for a fee, at the NRC Public Document Room,
2120 L Street, N.W., Lower Level, Washington, DC 20555, telephone (202)
634-3273, on or about November 22, 1996. Minutes of the meeting will be
available on or about December 20, 1996.
4. Seating for the public will be on a first-come, first-served basis.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in Title
10, U.S. Code of Federal Regulations, Part 7.
Dated: October 15, 1996.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 96-26888 Filed 10-18-96; 8:45 am]
BILLING CODE 7590-01-P
